OHSU in the news

An old-but-new treatment for opioid addiction

Townsend Letter April 02, 2021
Erick Turner, M.D., questions the use of Vitamin C to treat opioid use disorder. He says, “On the face of it, it doesn’t seem biologically plausible. How/why would vitamin C affect opioid receptors? Even if there were some plausible sounding mechanism, that’s no substitute for rigorous data.”

Former AG Holder to investigate OHSU harssment complaints

The Associated Press March 30, 2021
Former U.S. Attorney General Eric Holder of Covington & Burling LLC will lead a comprehensive, independent investigation of institutional harassment, discrimination, retaliation and racism at OHSU.

Vaccine clinic held in Portland for BIPOC community

KPTV March 29, 2021
OHSU partnered with Multnomah County’s Racial and Ethnic Approaches to Community Health program to organize a community vaccine clinic at Emmanuel Temple Church in Portland March 28-29 to improve vaccine access for local communities of color. Donn Spight, M.D., said: “Many different groups of color have been disproportionately impacted by COVID and find themselves limited by structural barriers to access and oftentimes concern about the safety and efficacy of the vaccine.”

OHSU launches long-haul COVID program

OPB's Think Out Loud March 29, 2021
While describing OHSU’s new Long COVID-19 Program for patients who have experienced coronavirus symptoms for more than a month, Eric Herman, M.D., says: "There are still many questions we're looking for answers to. Despite that I think that we can offer many things to patients to accelerate their healing and get better."

Flying an incomplete airplane

The Mail Tribune March 27, 2021
A year since the onset of the pandemic, story highlights laboratories at OHSU, the University of Oregon and Oregon State University studying virus mutations.

HIV vaccine candidate's mysteries unlocked 20 years later

Medical Xpress March 25, 2021
Studies published in Science and Science Immunology and led by Louis Picker, M.D., and Klaus Frueh, Ph.D., describe the biological mechanisms that make OHSU’s cytomegalovirus-based vaccine candidate effective at stopping and clearing HIV.
See more stories